Navigation Links
'We Keep Moving' Project Seeks Stories of People Across the Country Living With and Affected by MS
Date:2/12/2010

NEW YORK, N.Y., Feb. 12 /PRNewswire/ -- For every person living with and affected by MS there is a unique story about how they move forward with their lives.  That is why the National Multiple Sclerosis Society is launching We Keep Moving, a viewer-driven reality campaign that will capture these stories and perspectives through online videos that chronicle how people across the country keep moving forward while living with MS.  

Tell your story today!

Starting today through February 26, people living with and affected by MS are invited to submit a story at www.wekeepmoving.org for consideration. The program aims to not only share the stories of people living with MS -- a chronic illness whose symptoms can come and go without warning -- but also caregivers, families, loved ones and those who raise funds for the cause.

Online Viewers Will Drive the Reality Campaign

A committee that includes people living with MS will review all story submissions to select the finalists. For ten weeks beginning March 9, finalist stories will be shared at the program's Web site, where the public will vote to decide which story will be filmed and where our road crew will travel next on this cross-country journey.  

The road crew is made up of three creative professionals whose lives share a common bond: all of them are living with MS and are on their own journeys to share what it means to live with a disease whose hallmark is unpredictability.  To learn more about these three individuals, visit www.wekeepmoving.org.

The We Keep Moving Web site and videos are supported in part by Novartis Pharmaceuticals Corporation.

About Multiple Sclerosis

Multiple sclerosis, an unpredictable, often disabling disease of the central nervous system, interrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to loss of vision and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 400,000 people in the U.S. and over 2.1 million worldwide.

About the National Multiple Sclerosis Society

MS stops people from moving. The National MS Society exists to make sure it doesn't. We help each person address the challenges of living with MS. In 2008 alone, through our national office and 50 state network of chapters, we devoted over $148 million to programs that enhanced more than one million lives.  To move us closer to a world free of MS, the Society also invested over $45 million to support 440 research projects around the world.  We are people who want to do something about MS NOW. Join the movement at www.nationalMSsociety.org.

To learn more about MS and your options, talk to your health care professional and contact the National MS Society at nationalMSsociety.org or 1-800-FIGHT-MS (344-4867).

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

For decades, Novartis Pharmaceuticals Corporation and its affiliates have made significant advances in neuroscience, changing the way we treat disorders of the central nervous system (CNS).  Novartis has pioneered early breakthrough treatments for many neurological and psychiatric conditions, some of which remain important treatments to this day.   In the area of multiple sclerosis (MS), Novartis is committed to working with the community to provide advanced therapeutics and novel solutions to people living with the disease.  

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, preventive vaccines, diagnostic tools, cost-saving generic pharmaceuticals, and consumer health products. Novartis is the only company with leading positions in these areas.  Novartis Group companies are headquartered in Basel, Switzerland.  For more information, please visit http://www.novartis.com.

SOURCE National Multiple Sclerosis Society

RELATED LINKS
http://www.wekeepmoving.org

'/>"/>

SOURCE National Multiple Sclerosis Society
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
2. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
3. Masimo Expands its Irvine, California Corporate Headquarters to Accommodate Growth Projections
4. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
5. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
6. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
7. Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays? ECRI Institute outlines best practices to ensure better outcomes
8. VirtualScopics Project Balance Exceeds a Record $35 Million
9. Project Zero Delay Accelerates Drugs Path to Clinical Trial
10. New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects
11. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... 2017 , ... The Patient Advocacy Community of The Beryl Institute presented Eve ... Ravich Patient Advocacy Award in recognition of her extraordinary contributions to the field ... at The Beryl Institute’s annual Patient Experience Conference on March 20 in ...
(Date:4/21/2017)... Sterling, VA (PRWEB) , ... April 21, 2017 ... ... hosting its first weeklong campaign, AWARE: A Week of Addiction and Recovery Education, ... emerging evidence in treating and preventing substance use disorders. , The mission ...
(Date:4/21/2017)... Malvern, Worcestershire, UK (PRWEB) , ... April 21, ... ... Queen’s Award for Enterprise in the category of International Trade, the UK’s most ... performance in international trade, which represents 95% of total revenues and has grown ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Westside ... experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become one ... to help my numerous clients over the years with all their dental needs,” said ...
(Date:4/21/2017)... ... 21, 2017 , ... Federal mandate, fines, controversy, questions about ... Obamacare program that most Republicans love to hate and Texas Agriculture Commissioner Sid ... , Like Obamacare, the Miller program centers upon a federal mandate. ...
Breaking Medicine News(10 mins):